Clinical Trial Update: Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers [Phase 2]

View source ↗

Summary

Phase 2 trial examining intermittent or continuous acetylsalicylic acid (aspirin) and gene expression in nasal tissue of current smokers; completed with posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Carcinoma
• Tobacco Use Disorder

Drugs mentioned

• Acetylsalicylic acid (Aspirin)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lung Carcinoma, Tobacco Use Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-08-29